Catégorie : Points saillants de la recherche

New radiotracers could be key for new treatments and early detection for Parkinson’s

New radiotracers could be key for new treatments and early detection for Parkinson’s

Nuclear medicine researcher and GlycoNet Investigator Chris Phenix from the University of Saskatchewan has been awarded US$150,000 by The Michael J. Fox Foundation to develop diagnostic radiotracers for early detection of Parkinson’s Disease

fr_CAFrench
Scroll to Top